And we intend to advance our gene therapy asset AP103 into the clinic in 2022. With this transaction, we are also excited by the opportunity for ...
https://www.google.com/url?rct=j&sa=t&url=https://seekingalpha.com/article/4426117-amryt-pharma-plc-amyt-amryt-pharma-acquisition-of-chiasma-inc-and-q1-2021-earnings-conference&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNF1olLe2rrxV0MSO3Z7TkEfOvK08w
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.